Hepatitis C Viral RNA Genotype 1 NS3 Drug Resistance

Last Modified: 11/25/2019 11:09:11 AM

Medical Necessity Documentation:  
Client Notes:  
Patient Preparation:  
Specimen Requirements: 2.0 mL Plasma from a Lavender Top Tube - EDTA in a Plastic Vial
Collection Instructions: Separate plasma (preferred) from whole blood within 24 hours of collection by centrifugation at 800-1600 x g for 20 minutes at room temperature.
Transfer the plasma to a properly identified, sterile, polyproprylene screw-cap vial and ship refrigerated or frozen. 

Please note:
HCV genotype 1 is required for this test.
Minimum Volume: 0.6 mL Plasma
Transport & Storage: Temperature/Stability: 72 hours Refrigerated
42 days Frozen (Transport)
Rejection Criteria: Gross hemolysis • Gross lipemiaSpecimens using heparin as the anticoagulant • Ambient
Reference Range: Refer to Interpretive Results
Critical Ranges:  
Test Comments:  
Methodology: Polymerase chain reaction (PCR) • Sequencing
Clinical Significance: This assay may be used to detect grazoprevir, simeprevir and paritaprevir resistance-associated NS3 mutations in genotype 1 NS3 protease inhibitor treatment-experienced patients and also the Q80K polymorphism in patients being considered for a simeprevir-containing regimen.
Custom Panel: No


Turn Around Time: 4 to 11 days
Days Performed: Monday
PHL Test Code: HCN53
EPIC Test Code: LAB3007
Send Out Test Code: 90924
Alternate Test Names: Boceprevir Resistance; HCV NS3; NS3 Protease Mutations; NS3 Subtype,HCV; Q80K Polymorphism; Simeprevir Resistance; Telaprevir Resistance
Included Tests:  
CPT Coding: 87903

Go back to the top of the page.